Barry I Freedman1, Stephen S Rich, Hongrun Yu, Bong H Roh, Donald W Bowden. 1. Department of Internal Medicine, Section on Nephrology, The Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1053, USA. bfreedma@wfubmc.edu
Abstract
BACKGROUND: The human syntenic region of the rodent renal failure-1 gene (Rf1), an attractive candidate region for end-stage renal disease (ESRD) susceptibility, is located on chromosome 10q24-q26. In an attempt to assess for linkage between markers on human chromosome 10 and ESRD, we performed a linkage analysis in 356 African American sib pairs concordant for ESRD [199 sib pairs concordant for non-diabetic etiologies (hypertension-associated, chronic glomerulonephritis and unknown) and 157 sib pairs concordant for diabetic ESRD]. METHODS: Linkage was tested between 30 polymorphic markers spanning chromosome 10 and ESRD using GeneHunter software. RESULTS: In all 356 sib pairs, the maximum likelihood ratio z-score (Zlr) occurred near locus D10S677 (Zlr = 3.33, P = 0.0004, lod = 3.40), with a lesser peak near D10S1435 (Zlr = 1.77, P = 0.04, lod = 1.42). The locus at D10S677 contributed significantly to both diabetic ESRD (Zlr = 2.39, P = 0.008, lod = 2.08) and non-diabetic ESRD (Zlr = 2.35, P = 0.009, lod = 2.03). Additionally, the D10S677 peak was observed in both early onset (< or =50 years) and late onset (>50 years) ESRD (Zlr = 2.96, P = 0.002, lod = 2.82 in early onset and Zlr = 1.96, P = 0.03, lod = 1.60 in late onset ESRD families, respectively). The lesser peak at D10S1435 was observed in families with non-diabetic etiologies of ESRD (Zlr = 1.94, P = 0.02, lod = 1.58) and in those with early onset ESRD (Zlr = 1.89, P = 0.03, lod = 1.53). CONCLUSIONS: These results suggest that the region near D10S677, adjacent to the human homolog of the Rf1 gene, contributes to ESRD susceptibility in African Americans. They confirm that the region on 10p, near D10S1435, appears to be involved in early onset, non-diabetic etiologies of ESRD in African Americans.
BACKGROUND: The human syntenic region of the rodent renal failure-1 gene (Rf1), an attractive candidate region for end-stage renal disease (ESRD) susceptibility, is located on chromosome 10q24-q26. In an attempt to assess for linkage between markers on human chromosome 10 and ESRD, we performed a linkage analysis in 356 African American sib pairs concordant for ESRD [199 sib pairs concordant for non-diabetic etiologies (hypertension-associated, chronic glomerulonephritis and unknown) and 157 sib pairs concordant for diabetic ESRD]. METHODS: Linkage was tested between 30 polymorphic markers spanning chromosome 10 and ESRD using GeneHunter software. RESULTS: In all 356 sib pairs, the maximum likelihood ratio z-score (Zlr) occurred near locus D10S677 (Zlr = 3.33, P = 0.0004, lod = 3.40), with a lesser peak near D10S1435 (Zlr = 1.77, P = 0.04, lod = 1.42). The locus at D10S677 contributed significantly to both diabetic ESRD (Zlr = 2.39, P = 0.008, lod = 2.08) and non-diabetic ESRD (Zlr = 2.35, P = 0.009, lod = 2.03). Additionally, the D10S677 peak was observed in both early onset (< or =50 years) and late onset (>50 years) ESRD (Zlr = 2.96, P = 0.002, lod = 2.82 in early onset and Zlr = 1.96, P = 0.03, lod = 1.60 in late onset ESRD families, respectively). The lesser peak at D10S1435 was observed in families with non-diabetic etiologies of ESRD (Zlr = 1.94, P = 0.02, lod = 1.58) and in those with early onset ESRD (Zlr = 1.89, P = 0.03, lod = 1.53). CONCLUSIONS: These results suggest that the region near D10S677, adjacent to the human homolog of the Rf1 gene, contributes to ESRD susceptibility in African Americans. They confirm that the region on 10p, near D10S1435, appears to be involved in early onset, non-diabetic etiologies of ESRD in African Americans.
Authors: Ursula Vitt; Darryl Gietzen; Kristian Stevens; Jim Wingrove; Shanya Becha; Sean Bulloch; John Burrill; Narinder Chawla; Jennifer Chien; Matthew Crawford; Craig Ison; Liam Kearney; Mary Kwong; Joe Park; Jennifer Policky; Mark Weiler; Renee White; Yuming Xu; Sue Daniels; Howard Jacob; Michael I Jensen-Seaman; Jozef Lazar; Laura Stuve; Jeanette Schmidt Journal: Genome Res Date: 2004-04 Impact factor: 9.043
Authors: Jean W MacCluer; Marina Scavini; Vallabh O Shah; Shelley A Cole; Sandra L Laston; V Saroja Voruganti; Susan S Paine; Alfred J Eaton; Anthony G Comuzzie; Francesca Tentori; Dorothy R Pathak; Arlene Bobelu; Jeanette Bobelu; Donica Ghahate; Mildred Waikaniwa; Philip G Zager Journal: Am J Kidney Dis Date: 2010-06-19 Impact factor: 8.860
Authors: Fan Fan; Aron M Geurts; Mallikarjuna R Pabbidi; Ying Ge; Chao Zhang; Shaoxun Wang; Yedan Liu; Wenjun Gao; Ya Guo; Longyang Li; Xiaochen He; Wenshan Lv; Yoshikazu Muroya; Takashi Hirata; Jeremy Prokop; George W Booz; Howard J Jacob; Richard J Roman Journal: J Am Soc Nephrol Date: 2020-02-06 Impact factor: 10.121
Authors: Yuqing Chen; Rany M Salem; Fangwen Rao; Maple M Fung; Vibha Bhatnagar; Braj Pandey; Manjula Mahata; Jill Waalen; Caroline M Nievergelt; Michael S Lipkowitz; Bruce A Hamilton; Sushil K Mahata; Daniel T O'Connor Journal: Am J Nephrol Date: 2010-09-23 Impact factor: 3.754
Authors: Amy K Mottl; Suma Vupputuri; Shelley A Cole; Laura Almasy; Harald H H Göring; Vincent P Diego; Sandra Laston; Nora Franceschini; Nawar M Shara; Elisa T Lee; Lyle G Best; Richard R Fabsitz; Jean W MacCluer; Jason G Umans; Kari E North Journal: Kidney Int Date: 2008-08-13 Impact factor: 10.612
Authors: Liran I Shlush; Sivan Bercovici; Walter G Wasser; Guennady Yudkovsky; Alan Templeton; Dan Geiger; Karl Skorecki Journal: BMC Med Genomics Date: 2010-10-18 Impact factor: 3.063
Authors: Caitrin W McDonough; Meredith A Bostrom; Lingyi Lu; Pamela J Hicks; Carl D Langefeld; Jasmin Divers; Josyf C Mychaleckyj; Barry I Freedman; Donald W Bowden Journal: Hum Genet Date: 2009-12 Impact factor: 4.132
Authors: David J Friedman; Matthew E Talbert; Donald W Bowden; Barry I Freedman; Yves Mukanya; Keiichi Enjyoji; Simon C Robson Journal: Diabetes Date: 2008-12-18 Impact factor: 9.461